The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1968, 101: 1283-1290.
Copyright © 1968 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barth, R. F.
Right arrow Articles by Southworth, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Barth, R. F.
Right arrow Articles by Southworth, J.

Studies on Heterologous Antilymphocyte and Antithymocyte Sera

II. Effects on Cellular Antibody Production During the Early Primary and Secondary Immune Response of Mice to Sheep Erythrocytes

Rolf F. Barth1 and Joanne Southworth2

Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health

Abstract

The effects of rabbit antilymphocyte (ALS) and antithymocyte (ATS) sera on the early primary and secondary response of mice to sheep RBC were studied using the hemolytic plaque technique as an assay system for enumerating antibody-producing cells.

Immunosuppressive effectiveness was related to the routes of immunization and serum treatment. Intraperitoneal administration of ALS or ATS was the most effective in reducing the number of splenic plaque-forming cells (PFC), and intravenous administration was the least effective when associated with i.p. immunization.

Mice treated successively on days -1, 0 and +1 with 0.25 ml of ALS or ATS had a peak response of 4000 PFC by 76 hr following primary immunization compared to 387,000 for nontreated controls at 96 hr. There was a prolongation of the lag phase and a truncation of the exponential phase which may have been due to a reduction in the number of stimulated antigen sensitive precursor cells.

Mice treated with ALS or ATS at the time of primary immunization had a reduction in both unfacilitated and facilitated splenic PFC 3 days following a second injection of SRBC. Serum hemagglutinin and hemolysin titers were identical to controls, and it was suggested that peritoneal lymph nodes may have compensated for the decreased splenic response.

Infusion of ALS-treated and immunized mice with 50 x 106 spleen cells from normal syngeneic donors resulted in some restoration of immunocompetence both in terms of splenic PFC and serum antibodies.

Footnotes

1 Present address: Pathologic Anatomy Branch, National Cancer Institute

2 Present address: Department of Immunology, Duke University School of Medicine, Durham. North Carolina.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1968 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1968 by The American Association of Immunologists, Inc. All rights reserved.